Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Operating Expenses | 1,664 | 2,761 | 2,544 | 2,494 | 2,864 |
Operating Income | -1,664 | -2,761 | -2,544 | -2,494 | -2,864 |
Interest Expense | 60 | 32 | 0 | 0 | 0 |
Other Income | 71 | 75 | 63 | -1 | 66 |
Pre-tax Income | -1,654 | -2,717 | -2,481 | -2,496 | -2,798 |
Net Income Continuous | -1,654 | -2,717 | -2,481 | -2,496 | -2,798 |
Net Income | $-1,654 | $-2,717 | $-2,481 | $-2,496 | $-2,798 |
EPS Basic Total Ops | -0.06 | -0.11 | -0.10 | -0.10 | -0.11 |
EPS Basic Continuous Ops | -0.06 | -0.11 | -0.10 | -0.10 | -0.11 |
EPS Diluted Total Ops | -0.06 | -0.11 | -0.10 | -0.10 | -0.11 |
EPS Diluted Continuous Ops | -0.06 | -0.11 | -0.10 | -0.10 | -0.11 |
EPS Diluted Before Non-Recurring Items | -0.06 | -0.11 | -0.10 | -0.10 | -0.11 |
EBITDA(a) | $-1,605 | $-2,761 | $-2,544 | $-2,494 | $-2,864 |